BTSG · earnings call history
BrightSpring Q2 FY26 — Strong Revenue and EBITDA Growth Driven by Specialty Pharmacy and Provider Services
Read the briefBrightSpring Health Services Q1 FY26 — Strong Growth Across Pharmacy and Provider Segments
Read the briefBrightSpring Q4 FY25 — Strong Growth, Strategic Divestiture & Acquisitions, and Exceeded Leverage Targets
Read the briefBrowse all US companies on the earnings-call register.